Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DIFELIKEFALIN vs DIFLUNISAL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DIFELIKEFALIN vs DIFLUNISAL: Safety Overview

Metric DIFELIKEFALIN DIFLUNISAL
Total FAERS Reports 363 101
Deaths Reported 49 13
Death Rate 13.5% 12.9%
Hospitalizations 110 24
Average Patient Age 71.6 yrs 67.2 yrs
% Female Patients 40.1% 72.3%
FDA Approval Date Aug 23, 2021 Apr 19, 1982
Manufacturer Vifor (International), Inc. Zydus Pharmaceuticals (USA) Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued